SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Ball who started this subject8/22/2003 3:51:23 AM
From: mopgcw  Read Replies (1) of 496
 
GLFD US: S-3: GLFD Registers $69.3M of Conv. Notes for Holde
2003-08-21 18:18 (New York)

GUILFORD PHARMACEUTICALS INC ("GLFD-Q")
- S-3: GLFD Registers $69.3M of Conv. Notes for Holders

Guilford Pharmaceuticals Inc (Nasdaq NM: GLFD) filed an S-3 Thursday after the
market closed to register $69,354,000 of 5% Convertible Subordinated Notes due
July 1, 2008 and 11,114,423 shares of common stock issuable upon conversion of
the notes, for selling holders. The Company will not receive any of the proceeds
of sales by the selling security holders of any of the securities.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext